{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:51:37Z","timestamp":1782514297963,"version":"3.54.5"},"reference-count":55,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,9,22]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This nationwide study aimed to elucidate the incidence and clinical characteristics of tissue-verified sarcoidosis in Iceland. A secondary aim was to analyse sex differences and identify possible environmental factors contributing to the pathological process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This is a descriptive study covering 36\u2005years (January 1, 1981 through December 31, 2016). Histopathological reports and electronic hospital discharge registries were reviewed in context for granulomas and\/or sarcoidosis. National data were used for comparison regarding smoking habits and occupation, adjusted for age, sex and year of diagnosis. The data were stored in FileMaker and calculations were made by extracting data from this database to the statistical software package R.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 418 patients (54% females) were diagnosed with tissue-verified sarcoidosis. The incidence rate was 4.15\/100\u200a000\/year, similar among females and males. The mean age at diagnosis was higher among females (53.0\u00b114.2\u2005years) than males (48.2\u00b113.8\u2005years). Fatigue was the most frequent single symptom (49.7%), but when all respiratory symptoms were grouped, they were the most frequent symptoms (60%). No significant difference was found between smoking status and sarcoidosis. Possible hazardous exposure in the workplace was reported by 19.4% of the cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The incidence of sarcoidosis in Iceland was higher than in an Asian population where the same inclusion criteria were applied. The clinical picture diverges partly from that in the Asian population but resembles that among other Caucasians. Fatigue and respiratory symptoms were predominant. The biphasic pattern of age at disease debut seen elsewhere among females was not evident in Iceland.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00550-2021","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T13:58:19Z","timestamp":1633701499000},"page":"00550-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Sarcoidosis in Iceland: a nationwide study of epidemiology, clinical picture and environmental exposure"],"prefix":"10.1183","volume":"7","author":[{"given":"Sigr\u00ed\u00f0ur \u00d3l\u00edna","family":"Haraldsd\u00f3ttir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Gunnlaugur","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Bara","family":"Jorundsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haraldur Jon","family":"Hannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorarinn","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-6505","authenticated-orcid":false,"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"2024101711233362000_7.4.00550-2021.1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2014-132584"},{"key":"2024101711233362000_7.4.00550-2021.2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2024101711233362000_7.4.00550-2021.3","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8481-z"},{"key":"2024101711233362000_7.4.00550-2021.4","first-page":"83","article-title":"ACCESS: A Case Control Etiologic Study of Sarcoidosis","volume":"22","author":"Semenzato","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101711233362000_7.4.00550-2021.5","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"2024101711233362000_7.4.00550-2021.6","first-page":"113","article-title":"Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis","volume":"7","author":"Milman","year":"1990","journal-title":"Sarcoidosis"},{"key":"2024101711233362000_7.4.00550-2021.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016"},{"key":"2024101711233362000_7.4.00550-2021.8","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"2024101711233362000_7.4.00550-2021.9","first-page":"105","article-title":"[Sarcoidosis in Iceland 1981\u20132003]","volume":"93","author":"Haraldsdottir","year":"2007","journal-title":"Laeknabladid"},{"key":"2024101711233362000_7.4.00550-2021.10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12931-018-0871-3","article-title":"Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study","volume":"19","author":"Yoon","year":"2018","journal-title":"Respir Res"},{"key":"2024101711233362000_7.4.00550-2021.11","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.062836"},{"key":"2024101711233362000_7.4.00550-2021.12","first-page":"580","article-title":"Sarcoidosis among hospitalized patients in Poland: a national hospital register-based study","volume":"129","author":"Bogdan","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"2024101711233362000_7.4.00550-2021.13","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2024101711233362000_7.4.00550-2021.14","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046"},{"key":"2024101711233362000_7.4.00550-2021.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00075307"},{"key":"2024101711233362000_7.4.00550-2021.16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ijd.12633","article-title":"Epidemiology of sarcoidosis in Afro-Caribbean people: a 7-year retrospective study in Guadeloupe","volume":"54","author":"Coquart","year":"2015","journal-title":"Int J Dermatol"},{"key":"2024101711233362000_7.4.00550-2021.17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5152\/eurasianjmed.2017.17181","article-title":"Analysis of age distribution and disease presentation of 1269 patients with sarcoidosis","volume":"49","author":"Kocak","year":"2017","journal-title":"Eurasian J Med"},{"key":"2024101711233362000_7.4.00550-2021.18","first-page":"236905","article-title":"Sarcoidosis: sex-dependent variations in presentation and management","volume":"2014","author":"Birnbaum","year":"2014","journal-title":"J Ophthalmol"},{"key":"2024101711233362000_7.4.00550-2021.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(98)00058-8"},{"key":"2024101711233362000_7.4.00550-2021.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00991-2017"},{"key":"2024101711233362000_7.4.00550-2021.21","doi-asserted-by":"crossref","first-page":"537382","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front Immunol"},{"key":"2024101711233362000_7.4.00550-2021.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"2024101711233362000_7.4.00550-2021.23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jfo.2018.06.015","article-title":"[Sarcoidosis]","volume":"42","author":"Salah","year":"2019","journal-title":"J Fr Ophtalmol"},{"key":"2024101711233362000_7.4.00550-2021.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5261.1165"},{"key":"2024101711233362000_7.4.00550-2021.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0865CI"},{"key":"2024101711233362000_7.4.00550-2021.26","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8478-7"},{"key":"2024101711233362000_7.4.00550-2021.27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"2024101711233362000_7.4.00550-2021.28","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8475-x"},{"key":"2024101711233362000_7.4.00550-2021.29","doi-asserted-by":"publisher","DOI":"10.1136\/thx.43.4.342"},{"key":"2024101711233362000_7.4.00550-2021.30","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2114"},{"key":"2024101711233362000_7.4.00550-2021.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.5.1183"},{"key":"2024101711233362000_7.4.00550-2021.32","doi-asserted-by":"publisher","DOI":"10.1136\/thx.42.6.420"},{"key":"2024101711233362000_7.4.00550-2021.33","first-page":"325","article-title":"Sarcoidosis: a review for the internist","volume":"13","author":"Bargagli","year":"2018","journal-title":"Intern Emerg Med"},{"key":"2024101711233362000_7.4.00550-2021.34","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.11.2106001"},{"key":"2024101711233362000_7.4.00550-2021.35","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.094060"},{"key":"2024101711233362000_7.4.00550-2021.36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/crj.12213","article-title":"Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population","volume":"10","author":"Lill","year":"2016","journal-title":"Clin Respir J"},{"key":"2024101711233362000_7.4.00550-2021.37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2049-6958-8-5","article-title":"Husband and wife with sarcoidosis: possible environmental factors involved","volume":"8","author":"Leli","year":"2013","journal-title":"Multidiscip Respir Med"},{"key":"2024101711233362000_7.4.00550-2021.38","doi-asserted-by":"publisher","DOI":"10.1097\/01.jom.0000155711.88781.91"},{"key":"2024101711233362000_7.4.00550-2021.39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/occmed\/kqz118","article-title":"Silica dust and sarcoidosis in Swedish construction workers","volume":"69","author":"Jonsson","year":"2019","journal-title":"Occup Med"},{"key":"2024101711233362000_7.4.00550-2021.40","doi-asserted-by":"publisher","DOI":"10.1136\/oem.55.10.657"},{"key":"2024101711233362000_7.4.00550-2021.41","doi-asserted-by":"publisher","DOI":"10.1136\/thx.43.7.516"},{"key":"2024101711233362000_7.4.00550-2021.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.10.003"},{"key":"2024101711233362000_7.4.00550-2021.43","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209032"},{"key":"2024101711233362000_7.4.00550-2021.44","first-page":"455","article-title":"Seasonal clustering of sarcoidosis","volume":"2","author":"Bardinas","year":"1989","journal-title":"Lancet"},{"key":"2024101711233362000_7.4.00550-2021.45","first-page":"6","article-title":"Sarcoidosis","volume":"64","author":"Gudbrandsson","year":"1978","journal-title":"Laeknabladid"},{"key":"2024101711233362000_7.4.00550-2021.46","unstructured":"World Health Organization . International classification of diseases: [9th] ninth revision, basic tabulation list with alphabetic index. World Health Organization, 1978. https:\/\/apps.who.int\/iris\/handle\/10665\/39473"},{"key":"2024101711233362000_7.4.00550-2021.47","unstructured":"World Health Organization . International Statistical Classification of Diseases and Related Health Problems, 2016. https:\/\/icd.who.int\/browse10\/2016\/en"},{"key":"2024101711233362000_7.4.00550-2021.48","unstructured":"The Directorate of Health . T\u00f3baksnotkun - Smoking and tobacco consumption, 2020. www.landlaeknir.is\/tolfraedi-og-rannsoknir\/tolfraedi\/allt-talnaefni\/"},{"key":"2024101711233362000_7.4.00550-2021.49","unstructured":"International Labour Organization . International Standard Classification of Occupations, 2004. www.ilo.org\/public\/english\/bureau\/stat\/isco\/isco88\/index.htm"},{"key":"2024101711233362000_7.4.00550-2021.50","unstructured":"Statistics Iceland . Business sector. https:\/\/px.hagstofa.is:443\/pxis\/sq\/27223472-522f-489e-b139-d32b2dba0f12"},{"key":"2024101711233362000_7.4.00550-2021.51","first-page":"56s","article-title":"Sarcoidosis: clinical update","volume":"18","author":"Costabel","year":"2001","journal-title":"Eur Respir J"},{"key":"2024101711233362000_7.4.00550-2021.52","first-page":"113","article-title":"Clinical manifestation, prevalence and prognosis of sarcoid arthropathy. A nationwide study: the Icelandic Sarcoidosis Study","volume":"24","author":"Petursdottir","year":"2007","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101711233362000_7.4.00550-2021.53","first-page":"187","article-title":"Cigarette smoking and sarcoidosis","volume":"49","author":"Peros-Golubicic","year":"1995","journal-title":"Acta Med Croatica"},{"key":"2024101711233362000_7.4.00550-2021.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.036"},{"key":"2024101711233362000_7.4.00550-2021.55","doi-asserted-by":"crossref","unstructured":"Broos CE , Wapenaar M , Looman CWN , et al. Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis. Eur Respir J 2018; 51: 1702089. doi:10.1183\/13993003.02089-2017","DOI":"10.1183\/13993003.02089-2017"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00550-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:12:33Z","timestamp":1740373953000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00550-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,13]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1183\/23120541.00550-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00550-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}